Tuesday - February 24, 2026

Category Archives: Marketing & Sales

Matthew Chapman – Windermere Real Estate Named #1 Real Estate Agent in Bellevue by CX Research Institute

Independent research report ranks Bellevue-based agent highest for market expertise, mission-driven service model, and comprehensive representation approach Bellevue, WA – CX Research Institute announced today the publication of its comprehensive research report evaluating the best real estate agents in Bellevue, Washington, … Continue reading →

DUB Inhibitors Market to Surpass Multi-Billion-Dollar Milestone by 2040 Across 7MM | 8+ Companies Advancing 10+ Pipeline Therapies in Oncology & Neurodegeneration, analyses DelveInsight

DUB Inhibitors Market DUB Inhibitors Companies are InSilico Medicine, Molecure, KSQ Therapeutics, Roche, Mission Therapeutics, Cothera Bioscience, Asieris Pharmaceuticals, Tango Therapeutics, and others. The DUB inhibitors market is set to witness consistent expansion, fueled by increasing focus on targeted protein … Continue reading →

Ablation Devices Market to Reach USD 15,347.69 Million by 2032, Growing at 8.38% CAGR | Rising Cancer & Cardiac Arrhythmia Cases Drive Demand for Minimally Invasive Technologies, analyses DelveInsight

Ablation Devices Market Global Ablation Devices Market Forecast 2025–2032 Highlights Strong Growth Momentum Across Oncology, Cardiology, and Pain Management Applications The global Ablation Devices Market is poised for robust expansion, with market size projected to increase from USD 8,090.31 million … Continue reading →

Balloon Valvuloplasty Device Market to Grow at 5.13% CAGR Through 2032, Driven by Rising Cardiovascular Disease Burden and Demand for Minimally Invasive Cardiac Procedures, states DelveInsight

Balloon Valvuloplasty Device Market Balloon valvuloplasty device manufacturers include BD, PFM Medical ag, NuMED, Balton, TORAY INDUSTRIES, INC., Translumina, InterValve Medical, Inc., OSYPKA AG, SURETECH MEDICAL INC., simeks, and others. The global Balloon Valvuloplasty Device Market is poised for steady … Continue reading →

Insulin Resistance Pipeline Expands as 20+ Pharma Companies Progress Novel Therapies Toward Market Entry, Finds DelveInsight

Insulin Resistance – Pipeline Insight, 2026 DelveInsight’s “Insulin Resistance – Pipeline Insight, 2026” report provides comprehensive insights about 20+ companies, including Corbus Pharmaceuticals Holdings, Inc., Kura Oncology, Inc, SCOHIA Pharma Inc, Atrogi, YUNOVIA CO.,LTD., PegBio, Eli Lilly and Company, Tonix … Continue reading →